Renaissance of Vitamin D. molecular biological, physiological and pharmacological aspects
https://doi.org/10.21518/2079-701X-2015-18-102-103
Abstract
The article offers recent findings on Vitamin D, D hormone and D endocrine system, types of vitamin D deficiency and their role in the pathology. The questions of pharmacological management of various types of D-deficiency with natural vitamin preparations and its active metabolites are discussed.
About the Author
G. Y. Schwarz
First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Russian Federation
References
1. MeLLanby E. Experimental rickets. Medical Research (G.B.). Special Report Series SRS-61, 1-78.
2. Heaney RP. Vitamin D in Health and Disease. Clin J Am Soc Nephro. 2008. L3: 15351541.
3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007. 357: 266-281.
4. Шварц Г.Я. Витамин D и D-гормон. М.: Анахарсис. 2005. 152 с.
5. Шварц Г.Я. Типы дефицита витамина D и их фармакологическая коррекция. Лекарственные средства, 2011, 1: 33-42.
6. Palm L, DeLuca H. Vitamin D, disease and therapeutic opportunities. Narure Rev. Drug Discоvery, 2010. 9: 941-955.
7. Takahashi N, Udagawa N, Suda T. Vitamin D endocrine system and osteoclasts. BoneKEy Reports. 2014, 3. Article number: 495.
8. Adams JS, Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Arch. Biochem.Biophys., 2012. 523(1): 95-102.
9. Lanske B, Razzaque M. Vitamin D and aging: old concepts and new insights J.Nutr.Biochem., 2007. 18(12): 771-777.
10. Epstein S, Schneider E. Drug and Hormone Effects on Vitamin D Metabolism. In Vitamin D, Chapter 74. p. 1253-1290. 2nd Ed., Feldman, Pike, Glorueux Eds., Elsevier Inc., 2005.
11. Schwarts GG, Blot WJ. Vitamin D status and cancer incidence and mortality: something new under the Sun. J.Natl. Cancer Inst. 2006. 98(7): 428-430.
12. Vaidya A, Forman JP. Vitamin D and vascular disease: the current and future status of vitamin D therapy in hypertension and kidney disease. Curr.Hypertens.Rep. 2012. 14: 111-119.
13. Bajaj A, Stone K, Peters K et al. Circulating vitamin D, supplement use, and cardiovascular risk: the MrOS Sleep Study. J EndocrinolMetab., 2014. 99(9): 3256-3262.
14. Kostler K, Denzer N, Muller CS et al. The relevance of vitamin D receptor (VDR) gene polymorphism for cancer: a review of the literature. Anticancer Res., 2009. 29: 3511-3536.
15. Giovannnucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Ann. Intern. Med., 2008. 168: 1174-1180.
16. LaPrincess CB, Michos ED, Reis JP. Vitamin D in аtherosclerosis, vascular disease, and endothelial function. Curr. Drug Targets, 2011. 12: 54-60.
Review
For citations:
Schwarz GY. Renaissance of Vitamin D. molecular biological, physiological and pharmacological aspects. Meditsinskiy sovet = Medical Council. 2015;(18):102-103. (In Russ.) https://doi.org/10.21518/2079-701X-2015-18-102-103
Views:
751
Email this article 